Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry

Clinical Chemistry

Volumn 56, Issue 2, 2010, Pages 291-305

  Abbatiello, Susan E ^a   Mani, D R ^a   Keshishian, Hasmik ^a   Carr, Steven A ^a  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; HUMAN; ISOTOPE DILUTION ASSAY; MASS SPECTROMETRY; MULTIPLE MONITORING MASS SPECTROMETRY; PEPTIDE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; HUMANS; MASS SPECTROMETRY; PEPTIDES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 75749126208     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.138420     Document Type: Article

References (48)

1. Yost RA, Enke CG. Triple quadrupole mass spectrometry for direct mixture analysis and structure elucidation. Anal Chem 1979;51:1251-64.
2. Brumley WC, Sphon JA. Regulatory mass spectrometry. Biomed Mass Spectrom 1981;8:390-6.
3. Sphon JA. Use of mass spectrometry for confirmation of animal drug residues. J Assoc Off Anal Chem 1978;61:1247-52.
4. Vargo JD. Determination of sulfonic acid degradates of chloroacetanilide and chloroacetamide herbicides in groundwater by LC/MS/MS. Anal Chem 1998;70:2699-703.
5. Draisci R, Palleschi L, Ferretti E, Lucentini L, Cammarata P. Quantitation of anabolic hormones and their metabolites in bovine serum and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2000;870:511-22.
6. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin Biochem 2005;38:319-27.
7. Kuhara T. Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 2007;855:42-50.
8. Pitt JJ, Eggington M, Kahler SG. Comprehensive screening of urine samples from inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 2002;48:1970-80.
9. Stein SE, Heller DN. On the risk of false positive identification using multiple ion monitoring in qualitative mass spectrometry: large-scale intercomparisons with a comprehensive mass spectral library. J Am Soc Mass Spectrom 2006;17:823-35.
10. Bethem R, Boison J, Gale J, Heller D, Lehotay S, Loo J, et al. Establishing the fitness for purpose of mass spectrometric methods. J Am Soc Mass Spectrom 2003;14:528-41.
11. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal Chem 1998;70:882-9.
12. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom 2000;11:942-50.
13. Tang L, Kebarle P. Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution. Anal Chem 1993;65:3654-68.
14. Tiller PR, Romanyshyn LA. Implications of matrix effects in ultra-fast gradient or fast isocratic liquid chromatography with mass spectrometry in drug discovery. Rapid Commun Mass Spectrom 2002;16:92-8.
15. Browne TR. Stable isotopes in pharmacology studies: present and future. J Clin Pharmacol 1986;26:485-9.
16. Parsons HG. Stable isotopes in the management and diagnosis of inborn errors of metabolism. Can J Physiol Pharmacol 1990;68:950-4.
17. Moore LJ, Machlan LA. High accuracy determination of calcium in blood serum by isotope dilution mass spectrometry. Anal Chem 1972;44:2291-6.
18. Cohen A, Hertz HS, Mandel J, Paule RC, Schaffer R, Sniegoski LT, et al. Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. Clin Chem 1980;26:854-60.
19. Barr JR, Maggio VL, Patterson DG Jr, Cooper GR, Henderson LO, Turner WE, et al. Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 1996;42:1676-82.
20. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003;100:6940-5.
21. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007;6:2212-9.
22. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of Zn-α2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 2007;53:673-8.
23. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006;24:971-83.
24. Whiteaker JR, Zhao L, Zhang HY, Feng LC, Piening BD, Anderson L, Paulovich AG. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 2007;362:44-54.
25. Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT, et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin Chem 2009;55:1108-17.
26. Keshishian H, Addona T, Burgess M, Mani DR, Shi X, Kuhn E, et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009;8:2339-49.
27. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008;4:222.
28. Ciccimaro E, Hanks SK, Yu KH, Blair IA. Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry. Anal Chem 2009;81;3304-13.
29. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 2009;138:795-806.
30. Prakash A, Tomazela DM, Frewen B, MacLean B, Merrihew G, Peterman S, MacCoss MJ. Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. J Proteome Res 2009;8:2733-9.
31. Martin DB, Holzman T, May D, Peterson A, Eastham A, Eng J, McIntosh M. MRMer, an interactive open source and cross-platform system for data extraction and visualization of multiple reaction monitoring experiments. Mol Cell Proteomics 2008;7:2270-8.
32. Yan Z, Maher N, Torres R, Cotto C, Hastings B, Dasgupta M, et al. Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography/tandem mass spectrometric analysis of drug in biological matrix. Rapid Commun Mass Spectrom 2008;22:2021-8.
33. Abbatiello SE, Pan Y-X, Zhou M, Wayne AS, Veenstra TD, Hunger SP, et al. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. J Proteomics 2008;71:61-70.
34. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009;27:633-41.
35. R Development Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2008.
36. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289-300.
37. Brown MB. A method for combining non-independent one-sided tests of significance. Biometrics 1975;31:987-92.
38. Kost JT, McDermott MP. Combining dependent p-values. Stat Probab Lett 2002;60:183-90.
39. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005;21:3940-1.
40. Clauser KR, Baker P, Burlingame AL. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem 1999;71:2871-82.
41. Spengler B. De novo sequencing, peptide composition analysis, and composition-based sequencing: a new strategy employing accurate mass determination by Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 2004;15:703-14.
42. Jaffe JD, Keshishian H, Chang B, Addona TA, Gillette MA, Carr SA. Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification. Mol Cell Proteomics 2008;7:1952-62.
43. Sherman J, McKay MJ, Ashman K, Molloy MP. Unique ion signature mass spectrometry, a deterministic method to assign peptide identity. Mol Cell Proteomics 2009;8:2051-62.
44. Sun S, Meyer-Arendt K, Eichelberger B, Brown R, Yen CY, Old WM, et al. Improved validation of peptide MS/MS assignments using spectral intensity prediction. Mol Cell Proteomics 2007;6:1-17.
45. Holland JF, Sweeley CC, Thrush RE, Teets RE, Bieber MA. On-line computer controlled multiple ion detection in combined gas chromatography-mass spectrometry. Anal Chem 1973;45:308-14.
46. Fawcett T. ROC graphs: notes and practical considerations for researchers. Palo Alto (CA): HP Laboratories; 2004.
47. Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett 2006;27:861-74.
48. Heller DN. Guidance for industry: mass spectrometry for confirmation of the identity of animal drug residues. Report nr: guidance document 118. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Veterinary Medicine. Rockville (MD): FDA; 2003. 11 p.